Kapo Saukkonen

Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma

Kapo Saukkonen, 2018 .

Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma

C. Haglund, C. Holmberg, J. Hagström, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas

K. Jirström, C. Haglund, J. Hagström, 2020, Scientific Reports.

Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma

C. Haglund, L. Andersson, J. Hagström, 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

Harri Mustonen, Anne Juuti, Pauliina Kallio, 2016, BMC Cancer.

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

O. Nilsson, A. Juuti, S. Nordling, 2015, PloS one.

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

K. Alitalo, A. Juuti, S. Nordling, 2016, BMC Cancer.

PROX 1 and beta-catenin are prognostic markers in pancreatic ductal adenocarcinoma

K. Alitalo, A. Juuti, S. Nordling, 2022 .

TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT

C. Haglund, J. Hagström, C. Böckelman, 2020, Oncology.